Compare

Merck vs Pfizer

Merck (MRK) and Pfizer (PFE) side by side, from official filings: what insiders, members of Congress and funds reported. These are counts of what was filed, not a view on either stock.

Merck MRKNYSE · PharmaceuticalsPfizer PFENYSE · Pharmaceuticals
Insider records, last 12 months179110
Congress trades, last 12 months911
Fund positions reported, last 12 months451207
Federal contract awards, last 12 months1110
Open-market purchases by insiders since 20063025
Open-market sales by insiders since 2006391880
Last open-market purchase by an insiderFeb 7, 2025Aug 12, 2026
Next resultsOct 29, 2026Nov 3, 2026

Counts of records OQRO holds, by their date. Insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned and automatic sales are included in the sales.

Common questions

Which has had more insider buying, Merck or Pfizer?

Since 2006, Merck insiders reported 30 open-market purchases against 25 for Pfizer, in SEC Forms 4 and 5. Counts depend on the number of insiders and how long each company has been listed.

Do members of Congress trade MRK or PFE?

In the last 12 months, members of Congress disclosed 9 trades in Merck (MRK) and 11 in Pfizer (PFE), each reported as a value range on a periodic transaction report.

When did insiders last buy MRK and PFE?

Merck: Feb 7, 2025. Pfizer: Aug 12, 2026. Dates are those of the SEC filings.

See the record behind any of these

Each company page opens free with one real filing and the counts of the last 12 months. OQRO Pro adds the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.

Get OQRO ProOpen Merck free$9.99 a month, cancel anytime

Merck pagePfizer pageRare insider trades this weekAll comparisons

https://oqro.io/compare/mrk-vs-pfe